Editorial for “Preoperative Prediction of CDKN2A/B Homozygous Deletion Status in Astrocytoma: A Deep Learning‐Based Radiomics Model Using Magnetic Resonance Images

Journal of Magnetic Resonance ImagingEarly View Editorial Editorial for "Preoperative Prediction of CDKN2A/B Homozygous Deletion Status in Astrocytoma: A Deep Learning-Based Radiomics Model Using Magnetic Resonance Images Ekim Gumeler MD, Ekim Gumeler MD Department of Radiology, Hacettepe University, Ankara, TurkeySearch for more papers by this authorKader Karli Oguz MD, Corresponding Author Kader Karli Oguz MD [email protected] orcid.org/0000-0002-3385-4665 Department of Radiology, Neuroradiology Division, UC Davis Medical Center, Sacramento, California, USASearch for more papers by this author Ekim Gumeler MD, Ekim Gumeler MD Department of Radiology, Hacettepe University, Ankara, TurkeySearch for more papers by this authorKader Karli Oguz MD, Corresponding Author Kader Karli Oguz MD [email protected] orcid.org/0000-0002-3385-4665 Department of Radiology, Neuroradiology Division, UC Davis Medical Center, Sacramento, California, USASearch for more papers by this author First published: 12 June 2023 https://doi.org/10.1002/jmri.28846 Evidence Level: 5 Technical Efficacy: Stage 2 Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Louis DN, Perry A, Wesseling P, et al. The 2021 WHO classification of tumors of the central nervous system: A summary. Neuro Oncol 2021; 23(8): 1231-1251. 2Appay R, Dehais C, Maurage CA, et al. CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas. Neuro Oncol 2019; 21(12): 1519-1528. 3Brat DJ, Aldape K, Colman H, et al. cIMPACT-NOW update 5: Recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol (Berl) 2020; 139(3): 603-608. 4Patel SH, Poisson LM, Brat DJ, et al. T2-FLAIR mismatch, an imaging biomarker for IDH and 1p/19q status in lower-grade gliomas: A TCGA/TCIA project. Clin Cancer Res 2017; 23(20): 6078-6085. 5Park YW, Park KS, Park JE, et al. Qualitative and quantitative magnetic resonance imaging phenotypes may predict CDKN2A/B homozygous deletion status in isocitrate dehydrogenase-mutant astrocytomas: A multicenter study. Korean J Radiol 2023; 24(2): 133-144. 6Calabrese E, Rudie JD, Rauschecker AM, et al. Combining radiomics and deep convolutional neural network features from preoperative MRI for predicting clinically relevant genetic biomarkers in glioblastoma. Neuro Oncol Adv 2022; 4(1):vdac060. 7Chen S, Xu Y, Ye M, et al. Predicting MGMT promoter methylation in diffuse gliomas using deep learning with Radiomics. J Clin Med 2022; 11(12): 3445. 8Zhang et al. Preoperative prediction of CDKN2A/B homozygous deletion status in astrocytoma: a deep learning-based radiomics model using magnetic resonance images. J Magn Reson Imaging 2023; Epub ahead of print [Correction added on 12 July 2023, after the first online publication: The author's name has been changed to Zhang et al.]. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation